SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001161697-10-000663
Filing Date
2010-07-23
Accepted
2010-07-23 09:04:05
Documents
3
Period of Report
2010-07-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FOR 07-20-2010 form8-k.htm 8-K 17128
2 TERMINATION AGREEMENT ex101.htm EX-10 9878
3 PRESS RELEASE ISSUED ON JULY 22, 2010 ex991.htm EX-99 4992
  Complete submission text file 0001161697-10-000663.txt   33706
Mailing Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071
Business Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071 86-10-63899868
Lotus Pharmaceuticals, Inc. (Filer) CIK: 0001292087 (see all company filings)

IRS No.: 200507918 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32581 | Film No.: 10966160
SIC: 2834 Pharmaceutical Preparations